Literature DB >> 29798886

Race in America: What Does It Mean for Diabetes and CKD?

Katherine R Tuttle1.   

Abstract

Entities:  

Keywords:  Continental Population Groups; Renal Insufficiency, Chronic; clinical trials; diabetes mellitus; diabetic kidney disease; disparities; healthcare access and quality; social determinants of health

Mesh：

Year:  2018        PMID： 29798886      PMCID： PMC5989669          DOI： 10.2215/CJN.04890418

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Race and genomics.

Authors:  Richard S Cooper; Jay S Kaufman; Ryk Ward
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

2.  Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes.

Authors:  Claire Gerber; Xuan Cai; Jungwha Lee; Timothy Craven; Julia Scialla; Nao Souma; Anand Srivastava; Rupal Mehta; Amanda Paluch; Alexander Hodakowski; Rebecca Frazier; Mercedes R Carnethon; Myles Selig Wolf; Tamara Isakova
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-24       Impact factor: 8.237

3.  Biological races in humans.

Authors:  Alan R Templeton
Journal:  Stud Hist Philos Biol Biomed Sci       Date:  2013-05-16

Review 4.  Social Determinants of Racial Disparities in CKD.

Authors:  Jenna M Norton; Marva M Moxey-Mims; Paul W Eggers; Andrew S Narva; Robert A Star; Paul L Kimmel; Griffin P Rodgers
Journal:  J Am Soc Nephrol       Date:  2016-05-13       Impact factor: 10.121

5.  Community-Based CKD Screening in Black Americans.

Authors:  Keith C Norris; Susanne B Nicholas
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-15       Impact factor: 8.237

6.  Black Americans' Perspectives of Barriers and Facilitators of Community Screening for Kidney Disease.

Authors:  Ebele M Umeukeje; Marcus G Wild; Saugar Maripuri; Teresa Davidson; Margaret Rutherford; Khaled Abdel-Kader; Julia Lewis; Consuelo H Wilkins; Kerri Cavanaugh
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-15       Impact factor: 8.237

Review 7.  APOL1 Nephropathy: A Population Genetics and Evolutionary Medicine Detective Story.

Authors:  Etty Kruzel-Davila; Walter G Wasser; Karl Skorecki
Journal:  Semin Nephrol       Date:  2017-11       Impact factor: 5.299

8.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

9.  Vital Signs: Decrease in Incidence of Diabetes-Related End-Stage Renal Disease among American Indians/Alaska Natives - United States, 1996-2013.

Authors:  Ann Bullock; Nilka Ríos Burrows; Andrew S Narva; Karen Sheff; Israel Hora; Akaki Lekiachvili; Hannah Cain; David Espey
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-01-13       Impact factor: 17.586

10.  Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals.

Authors:  Nicholas S Downing; Nilay D Shah; Joseph H Neiman; Jenerius A Aminawung; Harlan M Krumholz; Joseph S Ross
Journal:  Trials       Date:  2016-04-14       Impact factor: 2.279
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.